HTBX has superior technology that recognizes and destroys all tumor released antigens and there is a lot of antigens that are released by tumors, while all other technologies recognize only one antigen at a time. Isn't that right? HTBX is also a vaccine and stimulator at the same time and other technologies are only one or the other. Isn't that right? Why is Juno worth $4 Billion while HTBX is worth only $50 Million? Doesn't it make HTBX a high value target?